Outsourcing STREAM
-
Navigating The Unique Attributes Of Psychedelic Drug Development
1/22/2024
Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.
-
Imagine⦠Easier, Proactive Drug Development
2/14/2023
Imagine partnering with a single CRO/CDMO for your early phase drug development. With Altasciences, you don’t have to imagine—learn how they’re able to deliver for your project.
-
Improving Sponsor Oversight Of The Trial Master File
2/15/2023
In the face of increasing documentation requirements and trial complexity, discover how global biopharmaceutical company Chiesi and its CRO partners collaborated to ensure ongoing oversight compliance.
-
Proactive Drug Development: Explained
1/30/2023
Watch this short video to learn about Proactive Drug Development with Altasciences.
-
Altasciences Clinical Services At A Glance
1/30/2023
We can support your entire drug development program end to end, or you can partner with us for just one element. We offer you complete flexibility.
-
Streamlining Patient Access To Cell And Gene Therapies
12/21/2023
Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.
-
Altasciences Has You Covered From Coast To Coast
1/30/2023
With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.
-
The Heart Of The Matter: Early Vs. Late QT Prolongation Testing
2/8/2023
Dr. Beatrice Setnik, Altasciences' Chief Scientific Officer, walks through the differences between early and late QT prolongation testing.
-
Big Impact With A Personal Touch
1/30/2023
Transforming lives. Improving human health. Bringing new therapies to life. Altasciences' CRO and CDMO services deliver.
-
Central eSource: Leveraging Site Technology
2/27/2025
In this presentation, CRIO founder and co-CEO Raymond Nomizu delves into how sponsors can leverage the electronic source trend among sites through the use of Central eSource.